According to a new report by Expert Market Research, the United States Heart Valve Devices Market reached a value of USD 3.93 Billion in 2025. The market is projected to grow at a CAGR of 9.6% during 2026-2035, ultimately attaining a value of USD 9.83 Billion by 2035. Expert Market Research highlights that the increasing burden of cardiovascular diseases, expanding elderly population, and rapid medical device innovation are supporting strong demand growth across the country.

The is witnessing substantial technological transformation with the growing adoption of minimally invasive surgical approaches and advanced replacement devices. Expert Market Research notes that healthcare providers are increasingly focusing on patient-centric treatment methods that improve recovery outcomes and reduce hospitalization periods.

The market is being driven by rising awareness regarding structural heart diseases, increasing investments in healthcare infrastructure, and continuous advancements in transcatheter valve replacement technologies. Growing demand for biological tissue valves and improved diagnostic capabilities are also contributing to broader adoption across hospitals and ambulatory surgical centers.

View a Sample Report – Includes Full Table of Contents

Expert Market Research indicates that strategic collaborations, product innovations, and increasing healthcare expenditure are expected to strengthen the competitive environment over the forecast period. The market outlook remains favorable due to evolving clinical practices and growing preference for minimally invasive treatment procedures.

Market Overview

The United States heart valve devices industry plays a vital role in the broader cardiovascular devices sector. Expert Market Research observes that the market is benefiting from increased prevalence of valvular heart disorders and rising patient awareness regarding advanced treatment solutions. Hospitals and specialized cardiac centers are integrating technologically advanced repair and replacement devices to improve procedural efficiency and patient survival outcomes. Biological tissue valves are gaining significant traction because of their compatibility and lower long-term complications, while mechanical valves continue to maintain relevance in critical treatment cases. The market also benefits from ongoing research activities, favorable reimbursement structures, and the strong presence of leading medical device manufacturers.

Market Size & Forecast: Expert Market Research Projections

Expert Market Research projects that the United States heart valve devices market, valued at USD 3.93 Billion in 2025, will grow at a CAGR of 9.6% during the forecast period of 2026-2035. The market is expected to achieve a valuation of USD 9.83 Billion by 2035, supported by advancements in minimally invasive technologies, increasing cardiovascular disease prevalence, and rising demand for innovative valve replacement and repair solutions.

Macroeconomic & Industry Linkage Analysis

The market is closely connected with broader healthcare spending patterns, demographic changes, and technological developments in cardiovascular care. Expert Market Research identifies that the growing aging population in the United States continues to increase the demand for effective heart valve treatment procedures. Improved healthcare accessibility and ongoing investments in specialized cardiac care facilities are further supporting market expansion.

In addition, the market is influenced by global supply chain developments and raw material availability. Expert Market Research notes that manufacturers are increasingly focusing on resilient supply networks, cybersecurity frameworks, and strategic sourcing of biocompatible materials used in valve production. Regulatory support and continuous clinical innovation are expected to further strengthen industry growth over the coming years.

Key Growth Drivers

• Rising Cardiovascular Disease Burden: Increasing prevalence of heart valve disorders is creating sustained demand for advanced treatment devices and surgical interventions.
• Growing Adoption of Minimally Invasive Procedures: Patients and healthcare providers are increasingly preferring minimally invasive surgeries due to faster recovery and reduced procedural risks.
• Technological Advancements: Continuous innovation in transcatheter valve technologies and biological tissue valves is enhancing treatment outcomes.
• Expanding Elderly Population: Aging demographics in the United States are significantly contributing to the growing need for heart valve replacement procedures.
• Strong Healthcare Infrastructure: Availability of advanced hospitals, specialized surgical centers, and skilled cardiac professionals supports market development.

Market Trends

Expert Market Research highlights that transcatheter valve replacement procedures are becoming increasingly popular due to their effectiveness in high-risk patient populations. Healthcare providers are emphasizing minimally invasive treatment methods to reduce patient recovery time and improve procedural efficiency.

Another major trend shaping the market is the growing demand for biological tissue valves. These valves are being widely adopted because of their compatibility and improved patient outcomes. Research activities focused on device durability and enhanced biocompatibility are expected to accelerate future innovation within the market.

Market Challenges & Risk Factors

The market faces challenges related to supply chain disruptions and rising raw material costs. Components used in heart valve manufacturing require specialized processing and transportation conditions, making the industry vulnerable to logistical constraints and geopolitical uncertainties.

Expert Market Research also notes that cybersecurity concerns and strict regulatory compliance requirements may create operational complexities for manufacturers. In addition, high procedure costs and limited accessibility in certain healthcare settings may affect adoption rates among some patient groups.

Market Opportunities & White Space Areas

The increasing focus on minimally invasive surgical techniques presents significant opportunities for manufacturers operating in the market. Companies investing in innovative replacement and repair devices are expected to gain competitive advantages in the evolving treatment landscape.

Emerging opportunities also exist in outpatient care settings and ambulatory surgical centers. Expert Market Research identifies that improved procedural efficiency and advancements in imaging technologies are supporting the expansion of heart valve procedures beyond traditional hospital environments.

Value Chain & Supply Chain Analysis

The value chain of the United States heart valve devices market includes raw material suppliers, device manufacturers, distributors, hospitals, ambulatory surgical centers, and end users. Expert Market Research states that maintaining reliable supply chains for specialized metals, biological tissues, and advanced medical components is essential for operational continuity. Manufacturers are increasingly focusing on quality assurance, regulatory compliance, and strategic partnerships to improve supply resilience and ensure consistent product availability across healthcare facilities.

Market Segmentation Analysis

Breakup By Valve Type

• Biological (Tissue) Valve
• Mechanical Valve

Breakup By Product Type

• Replacement Devices
• Repair Devices

Breakup By Procedure

• Open Surgery
• Minimally Invasive Surgery (MIS)

Breakup By End User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Others

Competitive Landscape

The competitive landscape of the United States heart valve devices market is characterized by continuous innovation, strategic partnerships, and strong research activities. Expert Market Research identifies leading companies focusing on advanced valve technologies, minimally invasive procedures, and product portfolio expansion to strengthen their market presence. Key players operating in the market include Medtronic plc, Edwards Lifesciences Corporation, Abbott, Corcym Group, Boston Scientific Corporation, Artivion, Inc, Micro Interventional Devices, Incorporated, Shockwave Medical Inc. (Johnson & Johnson, Services Inc.), and JenaValve Technology, Inc.

Frequently Asked Questions (FAQs)

1. What is the current size of the United States Heart Valve Devices Market?
The United States Heart Valve Devices Market was valued at USD 3.93 Billion in 2025.

2. What is the projected CAGR of the United States Heart Valve Devices Market?
Expert Market Research projects the market to grow at a CAGR of 9.6% during 2026-2035.

3. Which region dominates the United States Heart Valve Devices Market?
The United States remains the dominant region for the market due to advanced healthcare infrastructure and increasing cardiovascular treatment demand.

4. Who are the key players in the United States Heart Valve Devices Market?
Key players include Medtronic plc, Edwards Lifesciences Corporation, Abbott, Corcym Group, Boston Scientific Corporation, Artivion, Inc, Micro Interventional Devices, Incorporated, Shockwave Medical Inc. (Johnson & Johnson, Services Inc.), and JenaValve Technology, Inc.

5. What are the major growth drivers of the United States Heart Valve Devices Market?
Major growth drivers include rising cardiovascular disease prevalence, technological advancements, increasing elderly population, and growing adoption of minimally invasive surgeries.

6. What are the key segments of the United States Heart Valve Devices Market?
The market is segmented by valve type, product type, procedure, and end user.

7. What challenges does the United States Heart Valve Devices Market face?
The market faces challenges related to supply chain disruptions, rising raw material costs, cybersecurity concerns, and regulatory compliance requirements.

8. What is the forecast value of the United States Heart Valve Devices Market by 2035?
Expert Market Research estimates the market will reach USD 9.83 Billion by 2035.

"

About Us:

Expert Market Research is a global market intelligence and consulting platform by Claight delivering data-driven insights across commodities, chemicals, energy, and industrial markets. We design our research to support businesses, analysts, investors, and procurement teams in understanding price trends, supply-demand dynamics, competitive landscapes, gaining competitive intelligence, benchmarking best practices, and developing long-term market outlooks.

Our robust research methodologies, combined with validated primary and secondary data, ensure accuracy, consistency, and relevance. Our analysis is widely used not only for strategic planning, market-entry assessments, and sourcing decisions, but also for investment evaluation across international markets. Our strong emphasis on transparency, factual reporting, and regular data updates to reflect real-time market conditions always keeps you ahead of the curve.

Media Contact:

Company Name: Claight Corporation
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: C-130 Sector 2 Noida, Uttar Pradesh 201301
Website: https://www.expertmarketresearch.com